Home Search
chemotherapy - search results
If you're not happy with the results, please do another search
Immunoscore®: From the science to the clinical evidence in colon cancer
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Why cannabidiol really is the next big thing
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
We need to talk about access to medical cannabis
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Opportunities and solutions for acute promyelocytic leukaemia (APL)
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group gives an overall perspective on the challenges and concerns around acute promyelocytic leukaemia (APL), a type of blood cancer.
Insights into the mechanisms of primary brain tumour invasion
Thomas Daubon, Clotilde Billottet and Andreas Bikfalvi at the Angiogenesis and Tumor Microenvironment-INSERM U1029, Université Bordeaux provide insights into the mechanisms of primary brain tumour invasion.
Towards Precision Oncology in Breast Cancer
Predicting Response to Neoadjuvant Chemotherapy Using Tumor Vasculature Characteristics.
Cardiovascular disease: How to stop a killer
Cardiovascular disease claims the most lives every year but is largely preventable according to the President of the European Association of Preventive Cardiology, a branch of the European Society of Cardiology.
New treatments for neurodegenerative diseases
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
U.S. research on deafness and communication disorders
The National Institute on Deafness and Other Communication Disorders charts the work of their organisation over the last 30 years that concerns research around the communication sciences, including deafness.
Spotlight on tea’s top healthy ingredients
Tea is the nation’s favourite drink and for good reason: it not only tastes great, but it’s good for our wellbeing as it is full of healthy ingredients.
ChiLTERN: European project to improve outcome of children with liver cancer
In this analysis, Professor Keith Wheatley tells us about The ChiLTERN project, the most comprehensive research study ever undertaken in children’s liver cancer
Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond
Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.
Prostate cancer: A riddle wrapped in a mystery inside an enigma
Professor Malcolm Mason, Cancer Research UK’s Prostate Cancer Expert reveals why prostate cancer is a riddle wrapped in a mystery inside an enigma
New operating procedure gives hope to early-stage lung cancer
An innovative new surgery could provide a breakthrough in treating early-stage lung cancer, based on a review of some of the first patients to receive the treatment.
Cutting-edge technology synergy in the personalised nanomedicine space: Focus on pharmaceutical nanomanufacturing
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge technology synergy in the personalised nanomedicine space, with a special focus on pharmaceutical nanomanufacturing
Living with acute myeloid leukaemia (AML)
Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)
Aplastic anaemia and other rare bone marrow failures
Grazina Berry from Aplastic Anaemia Trust argues that young patients diagnosed with aplastic anaemia (AA) and other rare bone marrow failures need more help and support
Improving the care of children in Europe with rare cancer
The European Society for Paediatric Oncology together with Coordinators for the PARTNER Project and ERN PaedCan highlight the importance of collaboration in order to improve the care of children in Europe with rare cancer
Antiviral and antitumor therapies
Prof Dr Chris Meier at the University of Hamburg, Faculty of Sciences, Department of Chemistry explores antiviral and antitumor therapies. He discusses the intracellular delivery of antivirally active nucleoside triphosphates and argues that the ultimate challenge is applying these as chemotherapeutics